More annual reports from Kezar Life Sciences, Inc.:
2023 ReportPeers and competitors of Kezar Life Sciences, Inc.:
Brenntag20 September 2017 Company Announcements Office Australian Securities Exchange Level 40, Central Park 152-158 St Georges Terrace PERTH WA 6000 ADDENDUM TO 2017 ANNUAL REPORT – ADDITIONAL INFORMATION In accordance with ASX Listing Rule 4.10.19, the Company advises that it has used the cash and assets in a form readily convertible to cash that it had at the time of the Company’s admission to the Official List of ASX Limited on 12 January 2017 in a way consistent with its business objectives during the period from admission to 30 June 2017. Yours faithfully Bernard Crawford Company Secretary
Continue reading text version or see original annual report in PDF format above